Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)

ClinicalTrials.gov ID: NCT00252239

Public ClinicalTrials.gov record NCT00252239. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 24, 2026, 2:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2B Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)

Study identification

NCT ID: NCT00252239
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 2
Lead sponsor: University of Virginia; Other
Enrollment: 112 participants

Conditions and interventions

Conditions

Stroke

Interventions

tenecteplase Drug
tissue plasminogen activator, tPA Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 31, 2005
Primary completion: Feb 28, 2009
Completion: Aug 31, 2009
Last update posted: Mar 16, 2015

2005 – 2009

United States locations

U.S. sites: 9
U.S. states: 7
U.S. cities: 8

Facility	City	State	ZIP	Site status
University of California at San Diego	San Diego	California	92103-8466	—
Colorado Neurological Institutes	Englewood	Colorado	80113-2771	—
Johns Hopkins-Bayview Medical Center	Baltimore	Maryland	21224	—
University of Michigan	Ann Arbor	Michigan	48109-0316	—
Long Island Jewish Hospital	New Hyde Park	New York	11040	—
Mount Sinai Medical Center	New York	New York	10029	—
Columbia University, Statistical Analysis Center	New York	New York	10032	—
University of Texas at Houston	Houston	Texas	77030	—
University of Virginia Health System	Charlottesville	Virginia	22908	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00252239, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 16, 2015 · Synced Jul 24, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00252239 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →